Zifeng Huang Selected Research

Zifeng Huang Research Topics

Disease

11	Parkinson Disease (Parkinson's Disease) 12/2023 - 01/2019
4	Inflammation (Inflammations) 01/2022 - 08/2019
3	Ischemic Stroke 01/2021 - 01/2021
2	Dementia (Dementias) 01/2022 - 01/2021
2	Neuroinflammatory Diseases 01/2021 - 01/2021
1	Ganglion Cysts (Ganglion) 12/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023
1	Constipation 12/2023
1	Arthritis (Polyarthritis) 12/2023
1	Joint Diseases (Joint Disease) 12/2023
1	Hyperglycemia 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021
1	Disease Progression 02/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2020
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 01/2020
1	Osteoporotic Fractures 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Multiple Sclerosis 01/2020
1	Neuromyelitis Optica (Devic's Disease) 01/2020
1	Temporal Lobe Epilepsy 09/2019
1	Seizures (Absence Seizure) 09/2019
1	Cerebral Small Vessel Diseases 08/2019
1	Stroke (Strokes) 08/2019
1	Cognitive Dysfunction 08/2019
1	Ventricular Tachycardia 03/2018
1	Polymorphic catecholergic ventricular tachycardia 03/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2018
1	Syncope (Fainting) 03/2018
1	Sudden Death 03/2018
1	Heart Failure 08/2017
1	Anemia 08/2017
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 08/2017
1	Atrial Fibrillation 08/2017

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
2	Sorting NexinsIBA 01/2022 - 01/2021
2	IronIBA 01/2021 - 08/2017
2	Superoxide DismutaseIBA 01/2020 - 08/2019
1	Retinaldehyde (Retinal)IBA 12/2023
1	GlycolipidsIBA 01/2022
1	SphingolipidsIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	ProgranulinsIBA 12/2021
1	Glutathione (Reduced Glutathione)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Therapeutic UsesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	ApoferritinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Cystatin CIBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	alpha-SynucleinIBA 01/2021
1	SynucleinsIBA 01/2021
1	3-n-butylphthalide (butylphthalide)IBA 01/2021
1	Risedronic Acid (Actonel)FDA LinkGeneric 01/2020
1	romosozumabIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Teriparatide (Parathar)FDA Link 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Denosumab FDA Link 01/2020
1	Cold Shock Proteins and PeptidesIBA 01/2020
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2020
1	lipoprotein cholesterolIBA 01/2020
1	Kainic Acid (Kainate)IBA 09/2019
1	Proteins (Proteins, Gene)FDA Link 09/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2019
1	oxidized low density lipoproteinIBA 08/2019
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2018
1	Digoxin (Digitek)FDA LinkGeneric 08/2017

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023 - 10/2021
2	Therapeutics 01/2021 - 08/2017
1	Moxibustion 01/2021
1	Electroacupuncture 01/2021
1	Secondary Prevention 01/2020